Effects of Plyometric Training on Physical Fitness and Technical Skills in Young Male Volleyball Players.

January 18, 2024 updated by: Riphah International University
This study aims to find the effectiveness of Plyometric training on Physical fitness and Technical skills of young male volleyball players. Players would be taken from Prime Sports Academy and Prime Institute of Health Sciences, Islamabad and a well-designed Plyometric training plan will be implied on them for 8 weeks. After the time span, the result would be compared to check the effectiveness of the training plan.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Volleyball, invented by William Morgan in 1895, boasts a global participation of approximately 500 million people, making it a dynamic and fast-paced sport with diverse technical, tactical, and athletic demands. The game places high requirements on players' speed, agility, power, and strength. In the Netherlands, it is one of the most played team sports, with over 12,500 athletes participating. Volleyball is considered safer than other sports like football, handball, and basketball. Plyometric training (PT) is a key focus for coaches and professionals aiming to enhance players' conditioning capacities.

Plyometric jump training (PJT) has been identified as beneficial for both amateur and professional volleyball players, emphasizing the importance of training for repeated jumping, frequent sprinting, and directional changes. A meta-analysis by Ramirez et al. (2020) found that PJT effectively improved players in various age groups and genders while being deemed safe for volleyball players. Gjinovci et al. (2017) conducted a Randomized Control Trial, revealing greater improvements in plyometric group participants compared to skill-based training, particularly for sprinting, jumping, and throwing performance in players above 18 years of age.

Given the lack of a structured training plan for volleyball players, the study proposes implementing a structured plyometric training plan. This approach aims to enhance physical fitness and technical skills, including improved landing mechanics, increased explosive power, muscle strength, and agility. The study anticipates incorporating the structured plyometric training plan into the domestic players' training protocol, with a focus on improving rate of force development (RFD) for explosive movements such as jumping and spiking, as well as enhancing speed and agility for quick and coordinated on-court actions. The ultimate goal is to evaluate whether the proposed training plan positively impacts players' technical skills and physical fitness.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
28

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Pakistan
      • Islamabad, Pakistan
        • Recruiting
        • Prime Sports Academy & Prime Institute of Health Sciences
        • Contact:
        • Contact:
        • Principal Investigator:
          • Waqar A Awan, PhD
        • Principal Investigator:
          • Syed Aqil H Shah, MSPT*

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Young male healthy volleyball players aged 18-25 years, actively engaged in games for at least 6 months will be included in the study.

Exclusion Criteria:

  • Female players
  • History of trauma/injury in the last month.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Group-A (Plyometric training)
Other: Plyometric training

The group will receive plyometric exercises in a controlled environment. Following, Plyometrics would be performed.

  1. Leg hops
  2. Tuck jumps
  3. Vertical jumps
  4. Explosive push-ups
  5. Jumping spider
  6. Lateral/ diagonal and broad jumps
  7. Clapping push-ups
  8. Medicine ball presses
  9. Rotational throws
  10. Vertical and obstacle jumps
  11. Box shuffles
  12. Chest passes
  13. Box jumps
  14. Drop jumps
  15. Overarm throws
Other: Group-B (Conventional)
Other: Conventional

The group will receive conventional exercises in a controlled environment. Following, conventional exercises would be performed.

  1. Pushups.
  2. Situps.
  3. Lunges
  4. Squats
  5. 500m running

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Vertical jumping test
Time Frame: 8 weeks
Leg Power
8 weeks
Hand Dynamometer
Time Frame: 8 weeks
Hand Strength
8 weeks
1RM test
Time Frame: 8 weeks
Strength
8 weeks
30- Meter Sprint test.
Time Frame: 8 weeks
Speed
8 weeks
W-agility test
Time Frame: 8 weeks
Agility
8 weeks
2.4 km run test
Time Frame: 8 weeks
Endurance Test
8 weeks
Sit and Reach test.
Time Frame: 8 weeks
Flexibility
8 weeks
Abdominal Strength test.
Time Frame: 8 weeks
Abdominal strength
8 weeks
Ruler drop test.
Time Frame: 8 weeks
Reaction time
8 weeks
Medicine Ball Put Test
Time Frame: 8 weeks
8 weeks
Serving Test
Time Frame: 8 weeks
  • AAHPER Serving Test
  • AAHPERD Serving Test
8 weeks
BRUMBACH Serving Test
Time Frame: 8 weeks
8 weeks
Fore-arm Pass Test
Time Frame: 8 weeks
  • AAHPER Wall Volley
  • AAHPERD Pass-to-Self
8 weeks
Spiking Test
Time Frame: 8 weeks
AAHPERD Wall Spike
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Waqar Ahmed Awan, PHD, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 15, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 25, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 25, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 26, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 18, 2024

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 19, 2024

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 19, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 18, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 014245

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings